Cargando…

Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production

The biosynthesis of antifungal lipopeptides iturin and fengycin has attracted broad interest; however, there is a bottleneck in its low yield in wild strains. Because the key metabolic mechanisms in the lipopeptides synthesis pathway remain unclear, genetic engineering approaches are all ending up w...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Susheng, Wang, Rui, Zhao, Xiuyun, Ma, Gaoqiang, Liu, Na, Zheng, Yuqing, Tan, Jun, Qi, Gaofu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490133/
https://www.ncbi.nlm.nih.gov/pubmed/36159666
http://dx.doi.org/10.3389/fbioe.2022.961535
_version_ 1784793024799178752
author Wang, Susheng
Wang, Rui
Zhao, Xiuyun
Ma, Gaoqiang
Liu, Na
Zheng, Yuqing
Tan, Jun
Qi, Gaofu
author_facet Wang, Susheng
Wang, Rui
Zhao, Xiuyun
Ma, Gaoqiang
Liu, Na
Zheng, Yuqing
Tan, Jun
Qi, Gaofu
author_sort Wang, Susheng
collection PubMed
description The biosynthesis of antifungal lipopeptides iturin and fengycin has attracted broad interest; however, there is a bottleneck in its low yield in wild strains. Because the key metabolic mechanisms in the lipopeptides synthesis pathway remain unclear, genetic engineering approaches are all ending up with a single or a few gene modifications. The aim of this study is to develop a systematic engineering approach to improve the antifungal activity and biosynthesis of iturin and fengycin in Bacillus amyloliquefaciens. First, blocking the carbon overflow metabolic pathway to increase precursor supply of the branched-chain amino acids by knockout of bdh, disrupting sporulation to extend the stage for producing antifungal lipopeptides by deletion of kinA, blocking of siderophore synthesis to enhance the availability of amino acids and fatty acids by deletion of dhbF, and increasing Spo0A∼P by deletion of rapA, could improve the antifungal activity by 24%, 10%, 13% and 18%, respectively. Second, the double knockout strain ΔbdhΔkinA, triple knockout strain ΔbdhΔkinAΔdhbF and quadruple knockout strain ΔkinAΔbdhΔdhbFΔrapA could improve the antifungal activity by 38%, 44% and 53%, respectively. Finally, overexpression of sfp in ΔkinAΔbdhΔdhbFΔrapA further increased the antifungal activity by 65%. After purifying iturin and fengycin as standards for quantitative analysis of lipopeptides, we found the iturin titer was 17.0 mg/L in the final engineered strain, which was 3.2-fold of the original strain. After fermentation optimization, the titer of iturin and fengycin reached 31.1 mg/L and 175.3 mg/L in flask, and 123.5 mg/L and 1200.8 mg/L in bioreactor. Compared to the original strain, the iturin and fengycin titer in bioreactor increased by 22.8-fold and 15.9-fold in the final engineered strain, respectively. This study may pave the way for the commercial production of green antifungal lipopeptides, and is also favorable for understanding the regulatory and biosynthetic mechanism of iturin and fengycin.
format Online
Article
Text
id pubmed-9490133
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Frontiers Media S.A.
record_format MEDLINE/PubMed
spelling pubmed-94901332022-09-22 Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production Wang, Susheng Wang, Rui Zhao, Xiuyun Ma, Gaoqiang Liu, Na Zheng, Yuqing Tan, Jun Qi, Gaofu Front Bioeng Biotechnol Bioengineering and Biotechnology The biosynthesis of antifungal lipopeptides iturin and fengycin has attracted broad interest; however, there is a bottleneck in its low yield in wild strains. Because the key metabolic mechanisms in the lipopeptides synthesis pathway remain unclear, genetic engineering approaches are all ending up with a single or a few gene modifications. The aim of this study is to develop a systematic engineering approach to improve the antifungal activity and biosynthesis of iturin and fengycin in Bacillus amyloliquefaciens. First, blocking the carbon overflow metabolic pathway to increase precursor supply of the branched-chain amino acids by knockout of bdh, disrupting sporulation to extend the stage for producing antifungal lipopeptides by deletion of kinA, blocking of siderophore synthesis to enhance the availability of amino acids and fatty acids by deletion of dhbF, and increasing Spo0A∼P by deletion of rapA, could improve the antifungal activity by 24%, 10%, 13% and 18%, respectively. Second, the double knockout strain ΔbdhΔkinA, triple knockout strain ΔbdhΔkinAΔdhbF and quadruple knockout strain ΔkinAΔbdhΔdhbFΔrapA could improve the antifungal activity by 38%, 44% and 53%, respectively. Finally, overexpression of sfp in ΔkinAΔbdhΔdhbFΔrapA further increased the antifungal activity by 65%. After purifying iturin and fengycin as standards for quantitative analysis of lipopeptides, we found the iturin titer was 17.0 mg/L in the final engineered strain, which was 3.2-fold of the original strain. After fermentation optimization, the titer of iturin and fengycin reached 31.1 mg/L and 175.3 mg/L in flask, and 123.5 mg/L and 1200.8 mg/L in bioreactor. Compared to the original strain, the iturin and fengycin titer in bioreactor increased by 22.8-fold and 15.9-fold in the final engineered strain, respectively. This study may pave the way for the commercial production of green antifungal lipopeptides, and is also favorable for understanding the regulatory and biosynthetic mechanism of iturin and fengycin. Frontiers Media S.A. 2022-09-07 /pmc/articles/PMC9490133/ /pubmed/36159666 http://dx.doi.org/10.3389/fbioe.2022.961535 Text en Copyright © 2022 Wang, Wang, Zhao, Ma, Liu, Zheng, Tan and Qi. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
spellingShingle Bioengineering and Biotechnology
Wang, Susheng
Wang, Rui
Zhao, Xiuyun
Ma, Gaoqiang
Liu, Na
Zheng, Yuqing
Tan, Jun
Qi, Gaofu
Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production
title Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production
title_full Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production
title_fullStr Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production
title_full_unstemmed Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production
title_short Systemically engineering Bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production
title_sort systemically engineering bacillus amyloliquefaciens for increasing its antifungal activity and green antifungal lipopeptides production
topic Bioengineering and Biotechnology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9490133/
https://www.ncbi.nlm.nih.gov/pubmed/36159666
http://dx.doi.org/10.3389/fbioe.2022.961535
work_keys_str_mv AT wangsusheng systemicallyengineeringbacillusamyloliquefaciensforincreasingitsantifungalactivityandgreenantifungallipopeptidesproduction
AT wangrui systemicallyengineeringbacillusamyloliquefaciensforincreasingitsantifungalactivityandgreenantifungallipopeptidesproduction
AT zhaoxiuyun systemicallyengineeringbacillusamyloliquefaciensforincreasingitsantifungalactivityandgreenantifungallipopeptidesproduction
AT magaoqiang systemicallyengineeringbacillusamyloliquefaciensforincreasingitsantifungalactivityandgreenantifungallipopeptidesproduction
AT liuna systemicallyengineeringbacillusamyloliquefaciensforincreasingitsantifungalactivityandgreenantifungallipopeptidesproduction
AT zhengyuqing systemicallyengineeringbacillusamyloliquefaciensforincreasingitsantifungalactivityandgreenantifungallipopeptidesproduction
AT tanjun systemicallyengineeringbacillusamyloliquefaciensforincreasingitsantifungalactivityandgreenantifungallipopeptidesproduction
AT qigaofu systemicallyengineeringbacillusamyloliquefaciensforincreasingitsantifungalactivityandgreenantifungallipopeptidesproduction